Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 3cok | ANP | Serine/threonine-protein kinase PLK4 | 2.7.11.21 |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 3cok | ANP | Serine/threonine-protein kinase PLK4 | 2.7.11.21 | 1.000 | |
| 4c3p | ACP | Aurora kinase A | 2.7.11.1 | 0.528 | |
| 2qoq | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.508 | |
| 4qml | ANP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.503 | |
| 2c6e | HPM | Aurora kinase A | 2.7.11.1 | 0.501 | |
| 4jbo | WPH | Aurora kinase A | 2.7.11.1 | 0.499 | |
| 4o0u | ADN | Aurora kinase A | 2.7.11.1 | 0.496 | |
| 1mqb | ANP | Ephrin type-A receptor 2 | 2.7.10.1 | 0.491 | |
| 2wqe | ADP | Aurora kinase A | 2.7.11.1 | 0.491 | |
| 2ijm | ATP | Focal adhesion kinase 1 | 2.7.10.2 | 0.490 | |
| 2j0l | ANP | Focal adhesion kinase 1 | 2.7.10.2 | 0.490 | |
| 1i44 | ACP | Insulin receptor | 2.7.10.1 | 0.487 | |
| 4jbp | YPH | Aurora kinase A | 2.7.11.1 | 0.487 | |
| 4yhj | AN2 | G protein-coupled receptor kinase 4 | 2.7.11.16 | 0.486 | |
| 4j99 | ACP | Fibroblast growth factor receptor 2 | / | 0.483 | |
| 2hen | ADP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.481 | |
| 3c4x | ATP | Rhodopsin kinase | / | 0.480 | |
| 5l8l | ADP | Aurora kinase A | 2.7.11.1 | 0.478 | |
| 2qo7 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.477 | |
| 3c4w | ATP | Rhodopsin kinase | / | 0.477 | |
| 3c4z | ADP | Rhodopsin kinase | / | 0.463 | |
| 2w7x | D1A | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.461 | |
| 3t8o | ATP | Rhodopsin kinase | / | 0.461 | |
| 4mcv | 29K | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.461 | |
| 3a7h | ATP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.460 | |
| 3beg | ANP | SRSF protein kinase 1 | 2.7.11.1 | 0.459 | |
| 4l9i | 8PR | Rhodopsin kinase | / | 0.458 | |
| 3fzp | AGS | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.456 | |
| 4xlv | ACP | Insulin receptor | 2.7.10.1 | 0.456 | |
| 5dnr | ATP | Aurora kinase A | 2.7.11.1 | 0.456 | |
| 2j7t | 274 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.455 | |
| 2qoc | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.454 | |
| 4fg7 | ATP | Calcium/calmodulin-dependent protein kinase type 1 | 2.7.11.17 | 0.452 | |
| 3p23 | ADP | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.451 | |
| 5av3 | KMP | Death-associated protein kinase 1 | 2.7.11.1 | 0.451 | |
| 2vrx | 447 | Aurora kinase B-A | 2.7.11.1 | 0.450 | |
| 4ysj | ADP | Calmodulin-like domain protein kinase | / | 0.450 | |
| 3zxt | ACP | Death-associated protein kinase 1 | 2.7.11.1 | 0.449 | |
| 4qny | ANP | Mitogen activated protein kinase, putative | / | 0.449 | |
| 2cjm | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
| 5eg3 | ACP | Fibroblast growth factor receptor 2 | / | 0.448 | |
| 2v7a | 627 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.446 | |
| 2ycq | UPX | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.446 | |
| 2ojj | 82A | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.445 | |
| 2ijm | ADP | Focal adhesion kinase 1 | 2.7.10.2 | 0.444 | |
| 2vwu | 7X1 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.443 | |
| 4dee | ADP | Aurora kinase A | 2.7.11.1 | 0.443 | |
| 3d7t | STU | Tyrosine-protein kinase CSK | / | 0.442 | |
| 4i3z | ADP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
| 5av2 | KMP | Death-associated protein kinase 1 | 2.7.11.1 | 0.441 | |
| 3qc9 | ADP | Rhodopsin kinase | / | 0.440 |